Printer Friendly
The Free Library
14,508,411 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Research and Markets: AVANT Immunotherapeutics Inc - Deals and Alliances Report Provides an Unbiased, Accurate, Independent Approach to Company Analysis, Whether for Partnering or Investment Purposes.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c49832) has announced the addition of "AVANT Immunotherapeutics Inc - Deals and Alliances Report" to their offering.

The AVANT Immunotherapeutics Inc Deals & Alliances Report contains the company's contact information, business summary, company details, tables, graphs This partial list of graphs contains definitions of graphs and graph families which are known by particular names, but do not have a Wikipedia article of their own.

For collected definitions of graph theory terms that do not refer to individual graph types, such as
 and listings of the number of deals by deal category (product, technology, miscellaneous), stage of development, list of partners, deal types (licensing, marketing, etc.), top deals by deal value, partners based on technology with detailed descriptions of the partner firm where disclosed dis·close  
tr.v. dis·closed, dis·clos·ing, dis·clos·es
1. To expose to view, as by removing a cover; uncover.

2. To make known (something heretofore kept secret).
, partners based on product with detailed descriptions of the partner firm where disclosed, partners in other non-product, non-technology deals, with detailed descriptions of the partner firm and terms when available. The report also includes M&A statistics and recent partnering news updates by date.

Our products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes. They are based on the most comprehensive database of private and public biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 companies available.

Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. We distil dis·till also dis·til  
v. dis·tilled also dis·tilled, dis·till·ing also dis·til·ling, dis·tills also dis·tils

v.tr.
1. To subject (a substance) to distillation.

2.
 and systematize sys·tem·a·tize  
tr.v. sys·tem·a·tized, sys·tem·a·tiz·ing, sys·tem·a·tiz·es
To formulate into or reduce to a system: "The aim of science is surely to amass and systematize knowledge" 
 pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide the most comprehensive and up-to-date information available. The AVANT Immunotherapeutics Inc - Deals and Alliances Report therefore delivers the latest and the most comprehensive intelligence available on AVANT Immunotherapeutics Incs partnerships and M&A activity.
Topics Covered:

-Deals & Alliances
-Business Summary
-Contact Information
-Company Details
-No. of Deals by Deal Category
-List of Partners
-Deal Types (Table/Graph)
-No. of Deals by Stage of Development (Table/Graph)
-Top Deals by Deal Value
-Partners based on Product
-Miscellaneous Deals
-M&A Stats
-Recent Partnering Updates


For more information, visit http://www.researchandmarkets.com/reports/c49832
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 6, 2007
Words:291
Previous Article:In-Depth Company Profile for Westpac Banking Corporation Available Now.(Company overview)
Next Article:Spot Future Trends and Developments of the Non-Life Insurance Industry in China.
Topics:



Related Articles
AVANT Accelerates Receipt of $40 Million Milestone Payment for Rotarix(R).
AVANT Announces Latest GSK Report on Sales of Rotarix(R) Evidences Disagreement on Royalty Rate in Patent Countries.
Fiscal 2007 Defense Appropriations Bill Dedicates $2.6 Million to Ongoing Development of AVANT's Oral Anthrax/Plague Combination Vaccine.
Research and Markets: The CEL-SCI Corporation Competitor Report Provide An Unbiased, Accurate, Independent Approach To Company Analysis, Whether For...
Research and Markets: Gain An Insight In To AVI Biopharma Inc.
Research and Markets: Detailed Company Data Now Available on Pharmaceutical Company, Antisoma PLC.
AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines.
Research and Markets: Biogen Idec Inc - Deals And Alliances Report Delivers The Latest And The Most Comprehensive Intelligence Available On Biogen...
AVANT Restructures Organization to Focus Resources on Core Programs and Operations.
AVANT's Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles